Change in Item Category Names and Reorganization of Sales Classifications
First written in FY2024-Q1. 2 of 4 entries say "Restated". Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1ReframedAnnual report
「From the current interim consolidated accounting period, “Cerebrovascular,” which had previously been included in “Cardiovascular,” was changed to an independent new category. Comparisons with the previous interim consolidated accounting period were calculated using figures reclassified under the new categories. In addition, the product name “Open Stent Graft,” previously listed among the principal products in “Cardiovascular,” was changed to “Frozen Elephant Trunk.”」
Cerebrovascular was reorganised as an independent revenue category separate from Cardiovascular, and the product name Open Stent Graft was changed to Frozen Elephant Trunk. - FY2024-Q3RestatedAnnual report
「From the first quarter consolidated accounting period, the former “Surgical” category was renamed “Cardiovascular,” and the former “Gastrointestinal/PI” category was renamed “Gastrointestinal.” The atrial septal defect occluder was reclassified from the former “Gastrointestinal/PI” category to the new “Cardiovascular” category. Comparisons with the cumulative third quarter of the previous consolidated fiscal year were calculated using figures reclassified under the new categories.」
The renaming and reclassification of product categories implemented from the first quarter, along with the presentation of comparative figures for the same period of the previous year on a reclassified basis, continued in the third quarter. - FY2024-Q2RestatedAnnual report
「From the first quarter consolidated accounting period, the former “Surgical” category was renamed “Cardiovascular,” and the former “Gastrointestinal/PI” category was renamed “Gastrointestinal.” The atrial septal defect occluder was reclassified from the former “Gastrointestinal/PI” category to the new “Cardiovascular” category. Comparisons with the cumulative second quarter of the previous consolidated fiscal year were calculated using figures reclassified under the new categories.」
The renaming and reclassification of product categories implemented from the first quarter, along with the presentation of comparative figures for the same period of the previous year on a reclassified basis, continued in the second quarter. - FY2024-Q1First statedAnnual report
「From the first quarter of the current consolidated accounting period, the former “Surgical” category was renamed “Cardiovascular,” and the former “Gastrointestinal/PI” category was renamed “Gastrointestinal.” The atrial septal defect occluder was reclassified from the former “Gastrointestinal/PI” category to the new “Cardiovascular” category.」
From the first quarter, the names and classifications of product categories were changed, and the figures for the same period of the previous year were reclassified under the new categories for comparison.